Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection

Journal of Experimental Medicine

Volumn 204, Issue 4, 2007, Pages 929-940

  Ashton, Anthony W ^a   Mukherjee, Shankar ^a   Nagajyothi, F N U ^a   Huang, Huan ^a   Braunstein, Vicki L ^a   Desruisseaux, Mahalia S ^a   Factor, Stephen M ^a   Lopez, Lillie ^a   Berman, Joan W ^a   Wittner, Murray ^a   Scherer, Philipp E ^a   Capra, Valerie ^b   Coffman, Thomas M ^c   Serhan, Charles N ^d   Gotlinger, Katherine ^d   Wu, Kenneth K ^e   Weiss, Louis M ^a   Tanowitz, Herbert B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; THROMBOXANE SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GENE DELETION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; ACUTE DISEASE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHAGAS DISEASE; GENETICS; METABOLISM; MOUSE MUTANT; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; CHAGAS DISEASE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SIGNAL TRANSDUCTION; THROMBOXANE A2; TRYPANOSOMA CRUZI;

EID: 34247342059     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062432     Document Type: Article

References (66)

1. Tanowitz, H.B., L.V. Kirchhoff, D. Simon, S.A. Morris, L.M. Weiss, and M. Wittner. 1992. Chagas' disease. Clin. Microbiol. Rev. 5:400-419.
2. Ferreira, D., M. Cortez, V.D. Atayde, and N. Yoshida. 2006. Actin cytoskeleton-dependent and -independent host cell invasion by Trypanosoma cruzi is mediated by distinct parasite surface molecules. Infect. Immun. 74:5522-5528.
3. Cantarovich, F., M. Vazquez, W.D. Garcia, M. Abbud Filho, C. Herrera, and A. Villegas Hernandez. 1992. Special infections in organ transplantation in South America. Transplant. Proc. 24:1902-1908.
4. Leiby, D.A., R.M. Herron Jr., E.J. Read, B.A. Lenes, and R.J. Stumpf. 2002. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion. 42:549-555.
5. Vaidian, A.K., L.M. Weiss, and H.B. Tanowitz. 2004. Chagas' disease and AIDS. Kinetoplastid Biol. Dis. 3:2.
6. Petkova, S.B., H. Huang, S.M. Factor, R.G. Pestell, B. Bouzahzah, L.A. Jelicks, L.M. Weiss, S.A. Douglas, M. Wittner, and H.B. Tanowitz. 2001. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 31:499-511.
7. Factor, S.M., S. Cho, M. Wittner, and H. Tanowitz. 1985. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am. J. Trop. Med. Hyg. 34:246-253.
8. Petkova, S.B., H.B. Tanowitz, H.I. Magazine, S.M. Factor, J. Chan, R.G. Pestell, B. Bouzahzah, S.A. Douglas, V. Shtutin, S.A. Morris, et al. 2000. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 9:257-265.
9. Tanowitz, H.B., D.K. Kaul, B. Chen, S.A. Morris, S.M. Factor, L.M. Weiss, and M. Wittner. 1996. Compromised microcirculation in acute murine Trypanosoma cruzi infection. J. Parasitol. 82:124-130.
10. 2 in nonadherent human monocytes. J. Immunol. 158:351-358.
11. 2. FASEB J. 46:133-138.
12. Bove, A.A., R.E. Safford, J.M. Brum, Q. Sufan, and J.D. Dewey. 1986. Effects of thromboxane analog U46619 on endothelial damaged canine coronary arteries in vivo. Prostaglandins. 32:665-677.
13. 2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries. J. Am. Coll. Cardiol. 13:755-763.
14. Fitzgerald, D.J., L. Roy, F. Catella, and G.A. FitzGerald. 1986. Platelet activation in unstable coronary disease. N. Engl. J. Med. 315:983-989.
15. Huang, H., J. Chan, M. Wittner, L.A. Jelicks, S.A. Morris, S.M. Factor, L.M. Weiss, V.L. Braunstein, C.J. Bacchi, N. Yarlett, et al. 1999. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J. Mol. Cell. Cardiol. 31:75-88.
16. Teixeira, M.M., R.T. Gazzinelli, and J.S. Silva. 2002. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18:262-265.
17. Tanowitz, H.B., M. Wittner, S.A. Morris, W. Zhao, L.M. Weiss, V.B. Hatcher, V.L. Braunstein, H. Huang, S.A. Douglas, M. Valcic, et al. 1999. The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vascular tone induced by Trypanosoma cruzi. Endothelium. 6:217-230.
18. 2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells. Clin. Exp. Immunol. 120:71-78.
19. 2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts. Circulation. 94:742-747.
20. Ashton, A.W., G.M. Ware, D.K. Kaul, and J.A. Ware. 2003. Inhibition of tumor necrosis factor α-mediated NFκB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G protein-linked receptor (TP) ligands. J. Biol. Chem. 278:11858-11866.
21. Liu, L.X., C.N. Serhan, and P.F. Weller. 1990. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J. Exp. Med. 172:993-996.
22. Noverr, M.C., J.R. Erb-Downward, and G.B. Huffnagle. 2003. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin. Microbiol. Rev. 16:517-533.
23. Belley, A., and K. Chadee. 1995. Eicosanoid production by parasites: from pathogenesis to immunomodulation. Parasitol. Today. 11:327-334.
24. Kilunga Kubata, B., N. Eguchi, Y. Urade, K. Yamashita, T. Mitamura, K. Tai, O. Hayaishi, and T. Horii. 1998. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. J. Exp. Med. 188:1197-1202.
25. 2α synthase in Trypanosoma brucei. J. Exp. Med. 192:1327-1338.
26. Bustos, M., T.M. Coffman, S. Saadi, and J.L. Platt. 1997. Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2. J. Clin. Invest. 100:1150-1158.
27. Kubata, B.K., Z. Kabututu, T. Nozaki, C.J. Munday, S. Fukuzumi, K. Ohkubo, M. Lazarus, T. Maruyama, S.K. Martin, M. Duszenko, and Y. Urade. 2002. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. J. Exp. Med. 196:1241-1251.
28. 2 receptors in human vascular smooth muscle cells. Life Sci. 46:1765-1772.
29. Yu, I.S., S.R. Lin, C.C. Huang, H.Y. Tseng, P.H. Huang, G.Y. Shi, H.L. Wu, C.L. Tang, P.H. Chu, L.H. Wang, et al. 2004. TXAS-deleted mice exhibit normal thrombopoiesis, defective hemostasis, and resistance to arachidonate-induced death. Blood. 104:135-142.
30. 2. J. Clin. Invest. 102:1994-2001.
31. Thomas, D.W., P.N. Rocha, C. Nataraj, L.A. Robinson, R.F. Spurney, B.H. Koller, and T.M. Coffman. 2003. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J. Immunol. 171:6389-6395.
32. Fernandes, M., I. Irulegui, M.P. Deane, and C. Ruiz Rde. 1992. Trypanosoma cruzi: course of infection in platelets-depleted mice. Rev. Inst. Med. Trop. Sao Paulo. 34:9-13.
33. Umekita, L.F., R.M. Piazza, and I. Mota. 1994. Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi. Braz. J. Med. Biol. Res. 27:2391-2399.
34. Cardoni, R.L., M.T. Rimoldi, and M.M. de Bracco. 1984. Antibodydependent cytotoxicity of human and mouse mononuclear cells against Trypanosoma cruzi epimastigotes. Cell. Immunol. 86:518-524.
35. Liu, L.X., and P.F. Weller. 1990. Arachidonic acid metabolism in filaria parasites. Exp. Parasitol. 71:496-501.
36. Tanowitz, H.B., E.R. Burns, A.K. Sinha, N.N. Kahn, S.A. Morris, S.M. Factor, V.B. Hatcher, J.P. Bilezikian, S.G. Baum, and M. Wittner. 1990. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am. J. Trop. Med. Hyg. 43:274-281.
37. 2 receptor or protein kinase C. Biochem. J. 321:525-530.
38. 2-mimetic. Agents Actions Suppl. 45:47-52.
39. 2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration. Circ. Res. 95:372-379.
40. Mukherjee, S., H. Huang, S.B. Petkova, C. Albanese, R.G. Pestell, V.L. Braunstein, G.J. Christ, M. Wittner, M.P. Lisanti, J.W. Berman, et al. 2004. Trypanosoma cruzi infection activates extracellular signalregulated kinase in cultured endothelial and smooth muscle cells. Infect. Immun. 72:5274-5282.
41. Marcon, G.E., P.D. Andrade, D.M. de Albuquerque, S. Wanderley Jda, E.A. de Almeida, M.E. Guariento, and S.C. Costa. 2002. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn. Microbiol. Infect. Dis. 43:39-43.
42. Herrera, L., C. Martinez, H. Carrasco, A.M. Jansen, and S. Urdaneta-Morales. 2006. Cornea as a tissue reservoir of Trypanosoma cruzi. Parasitol Res. 100:1395-1399.
43. Combs, T.P., Nagajyothi, S. Mukherjee, C.J. de Almeida, L.A. Jelicks, W. Schubert, Y. Lin, D.S. Jayabalan, D. Zhao, V.L. Braunstein, et al. 2005. The adipocyte as an important target cell for Trypanosoma cruzi infection. J. Biol. Chem. 280:24085-24094.
44. Guarner, J., J. Bartlett, S.R. Zaki, D.G. Colley, M.J. Grijalva, and M.R. Powell. 2001. Mouse model for Chagas disease: immunohistochemical distribution of different stages of Trypanosoma cruzi in tissues throughout infection. Am. J. Trop. Med. Hyg. 65:152-158.
45. Monteon-Padilla, V., N. Hernandez-Becerril, M.A. Ballinas-Verdugo, A. Aranda-Fraustro, and P.A. Reyes. 2001. Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients. Arch. Med. Res. 32:39-43.
46. Tarleton, R.L. 2001. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 31:550-554.
47. Tarleton, R.L., and L. Zhang. 1999. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today. 15:94-99.
48. Zacks, M.A., J.J. Wen, G. Vyatkina, V. Bhatia, and N. Garg. 2005. An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. An Acad. Bras. Cienc. 77:695-715.
49. Teixeira, P.C., L.K. Iwai, A.C. Kuramoto, R. Honorato, A. Fiorelli, N. Stolf, J. Kalil, and E. Cunha-Neto. 2006. Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy. Braz. J. Med. Biol. Res. 39:1549-1562.
50. Tostes, S., Jr., D. Bertulucci Rocha-Rodrigues, G. de Araujo Pereira, and V. Rodrigues Jr. 2005. Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int. J. Cardiol. 99:233-237.
51. 2 receptors and the corresponding mRNAs in human eye tissue. Br. J. Ophthalmol. 78:921-926.
52. Matsumoto, S.C., V. Labovsky, M. Roncoroni, M.C. Guida, L. Gimenez, J. Mitelman, H. Gori, R. Jurgelevicius, A. Grillo, P. Manfredi, et al. 2006. Retinal dysfunction in patients with chronic Chagas' disease is associated to anti-Trypanosoma cruzi antibodies that cross-react with rhodopsin. FASEB J. 20:550-552.
53. Chaussabel, D., B. Pajak, V. Vercruysse, C. Bisseye, V. Garze, M. Habib, M. Goldman, M. Moser, and B. Vray. 2003. Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection. Lab. Invest. 83:1373-1382.
54. Albareda, M.C., S.A. Laucella, M.G. Alvarez, A.H. Armenti, G. Bertochi, R.L. Tarleton, and M. Postan. 2006. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int. Immunol. 18:465-471.
55. Mendes-da-Cruz, D.A., J. de Meis, V. Cotta-de-Almeida, and W. Savino. 2003. Experimental Trypanosoma cruzi infection alters the shaping of the central and peripheral T-cell repertoire. Microbes Infect. 5:825-832.
56. Laucella, S.A., M. Postan, D. Martin, B. Hubby Fralish, M.C. Albareda, M.G. Alvarez, B. Lococo, G. Barbieri, R.J. Viotti, and R.L. Tarleton. 2004. Frequency of interferon- gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infect. Dis. 189:909-918.
57. 2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4:694-701.
58. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med. 178:1825-1830.
59. Zuniga, E., E. Acosta-Rodriguez, M.C. Merino, C. Montes, and A. Gruppi. 2005. Depletion of immature B cells during Trypanosoma cruzi infection: involvement of myeloid cells and the cyclooxygenase pathway. Eur. J. Immunol. 35:1849-1858.
60. 2 involvement in experimental Trypanosoma cruzi infection. Clin. Immunol. Immunopathol. 81:122-128.
61. 2 involvement in experimental infection with Trypanosoma cruzi subpopulations. Prostaglandins. 49:141-153.
62. Walt, R.P., R.T. Kemp, B. Filipowicz, J.G. Davies, N.K. Bhaskar, and C.J. Hawkey. 1987. Gastric mucosal protection with selective inhibition of thromboxane synthesis. Gut. 28:541-544.
63. 2 pathway. Zentralbl. Veterinarmed. A. 46:123-131.
64. Tarzami, S.T., W. Miao, K. Mani, L. Lopez, S.M. Factor, J.W. Berman, and R.N. Kitsis. 2003. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection. Circulation. 108:2387-2392.
65. Tanowitz, H.B., K.S. Rowin, K. Roistacher, B. Nadal-Ginard, and M. Wittner. 1984. Trypanosoma cruzi: reversal of inhibition of host muscle differentiation after exposure to elevated temperatures. Exp. Parasitol. 58:307-313.
66. Campbell, W.B., and S.R. Ojeda. 1987. Measurement of prostaglandins by radioimmunoassay. Methods Enzymol. 141:323-341.